ZURICH, Jan 14 (Reuters) - A new Swiss production line where contract drugmaker Lonza (LONN.S), opens new tab is making active ingredients for Moderna's (MRNA.O), opens new tab COVID-19 vaccine is ...
MADRID, April 12 (Reuters) - Contract drugmaker Rovi is to make active ingredients for Moderna's COVID-19 vaccine, extending an existing agreement to bottle the vaccine using ingredients brought in ...
ZURICH (Reuters) - Contract drugmaker Lonza said on Monday it has begun manufacturing ingredients for Moderna Inc's COVID-19 vaccine from the first of three new Swiss production lines and expects the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback